Olopatadine Hydrochloride 68001-0530-69
- Manufacturer
- Bluepoint Laboratories
- Dosage Form
- Solution
- Route
- Ophthalmic
- Product Type
- Human Otc Drug
- Marketing Start
- April 8, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA209995
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olopatadine Hydrochloride | 2 mg/mL |
Drug Class
Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Selected Package
68001-0530-69Selected1 BOTTLE, PLASTIC in 1 CARTON (68001-530-69) / 2.5 mL in 1 BOTTLE, PLASTIC